- Comparison of WHO and RECIST Criteria for Response in Metastatic Colorectal Carcinoma
-
Choi JH, Ahn MJ, Rhim HC, Kim JW, Lee GH, Lee YY, Kim IS
- KMID: 2166118
- Cancer Res Treat.
- 2005 Oct;37(5):290-293.
PURPOSE: This study compared the WHO criteria with the response evaluation criteria in solid tumors (RECIST) in the same patients with metastatic colorectal cancer in order to determine the significance... -
- CITED
-
- Close
- SHARE
-
- Close
- Epstein-Barr Virus in Human Malignancy: A Special Reference to Epstein-Barr Virus associated Gastric Carcinoma
-
Chang MS, Kim WH
- KMID: 2166113
- Cancer Res Treat.
- 2005 Oct;37(5):257-267.
Epstein-Bar virus (EBV), a human herpesvirus, establishes a life-long persistent infection in 90~95% of human adult population worldwide. EBV is the etiologic agent of infectious mononucleosis, and EBV is associated... -
- CITED
-
- Close
- SHARE
-
- Close
- Treatment Outcomes of Three-Dimensional Conformal Radiotherapy for Stage III Non-Small Cell Lung Cancer
-
Yeo SG, Cho MJ, Kim SY, Lim SP, Kim KH, Kim JS
- KMID: 2166115
- Cancer Res Treat.
- 2005 Oct;37(5):273-278.
PURPOSE: To evaluate the treatment outcomes of the three-dimensional conformal radiotherapy (3D-CRT), in conjunction with induction chemotherapy, for the treatment of stage III non-small cell lung cancer (NSCLC). MATERIALS AND... -
- CITED
-
- Close
- SHARE
-
- Close
- Relationship between Pre-treatment Serum SCC (squamous cell carcinoma) Antigen, Cyfra 21-1 Levels, and Survival in Squamous Cell Carcinoma of the Uterine Cervix
-
Chang KH, Ryu HS, Chang SJ, Byun YJ, Lee JP
- KMID: 2166120
- Cancer Res Treat.
- 2005 Oct;37(5):302-306.
PURPOSE: To determine the relationship between pretreatment serum squamous cell carcinoma (SCC) antigen and Cyfra 21-1 levels, and survival in patients with invasive squamous cell carcinoma of the cervix. MATERIALS... -
- CITED
-
- Close
- SHARE
-
- Close
- Combination Chemotherapy of Oxaliplatin, 5-Fluorouracil and Low Dose Leucovorin in Patients with Advanced Colorectal Cancer
-
Shin YM, Han HS, Lim SW, Kim BC, Cheoi KS, Eum YO, Kim ST, Lee KH
- KMID: 2166117
- Cancer Res Treat.
- 2005 Oct;37(5):284-289.
PURPOSE: The aim of this study was to evaluate the efficacy and tolerability of the oxaliplatin, 5-fluorouracil (5-FU) and low dose leucovorin (LV) combination in patients with advanced colorectal cancer.... -
- CITED
-
- Close
- SHARE
-
- Close
- Oxaliplatin with Biweekly Low Dose Leucovorin and Bolus and Continuous Infusion of 5-fluorouracil (Modified FOLFOX 4) as a Salvage Therapy for Patients with Advanced Gastric Cancer
-
Suh SH, Kwon HC, Jo JH, Cho YR, Seo BG, Lee DM, Kim SH, Kim JS, Kim HJ
- KMID: 2166116
- Cancer Res Treat.
- 2005 Oct;37(5):279-283.
PURPOSE: To determine the activity and the toxicity associated with a low dose regimen of leucovorin (LV) plus 5-fluorouracil (5-FU) combined with oxaliplatin every two weeks (modified FOLFOX 4) as... -
- CITED
-
- Close
- SHARE
-
- Close
- Pattern of Apoptosis by NS398, a Selective COX-2 Inhibitor, in Hepatocellular Carcinoma Cell Lines
-
Park MK, Kim MK, Kim JC, Sung YK
- KMID: 2166122
- Cancer Res Treat.
- 2005 Oct;37(5):313-317.
PURPOSE: NS398, a selective COX-2 inhibitor, is known to inhibit the growth of COX-2 expressing hepatocellular carcinoma cells. The present study investigated whether the cytotoxic effect of NS398 was COX-2... -
- CITED
-
- Close
- SHARE
-
- Close
- Tetraarsenic Oxide-mediated Apoptosis in a Cervical Cancer Cell Line, SiHa
-
Kim J, Bae SM, Lim DS, Kwak SY, Lee CK, Lee YS, Bae IJ, Yoo JY, Lee YJ, Kim CK, Ahn WS
- KMID: 2166121
- Cancer Res Treat.
- 2005 Oct;37(5):307-312.
PURPOSE: Diarsenic oxide, As2O3, has been reported to be effective in treating acute leukemia, and induce apoptosis in many tumor cells. In this study, the ability of a novel arsenical... -
- CITED
-
- Close
- SHARE
-
- Close
- Results of Curative Radiation Therapy with or without Chemotherapy for Stage III Unresectable Non-Small Cell Lung Cancer
-
Ahn SJ, Kim YC, Kim KS, Park KO, Chung WK, Nam TK, Nah BS, Song JY, Yoon MS
- KMID: 2166114
- Cancer Res Treat.
- 2005 Oct;37(5):268-272.
PURPOSE: We retrospectively analyzed the patients who received curative radiotherapy for unresectable stage III NSCLC to investigate the impact of chemotherapy. MATERIALS AND METHODS: From 1998 to 2001, the records... -
- CITED
-
- Close
- SHARE
-
- Close
- Prognostic Factors in Non-Hodgkin's Lymphoma Patients Treated by Autologous Stem Cell Transplantation: A Single Center Experience
-
Suh C, Kim SH, Kim HJ, Jang G, Kim EK, Ko OB, Kim S, Sohn HJ, Lee JS, Kim W, Huh J
- KMID: 2166119
- Cancer Res Treat.
- 2005 Oct;37(5):294-301.
PURPOSE: Autologous stem cell transplantation (ASCT) is increasingly used in patients with non-Hodgkin's lymphoma (NHL). Various clinical parameters-were evaluated to obtain significant predictors of the outcome following ASCT in patients... -
- CITED
-
- Close
- SHARE
-
- Close
